This idea is consistent with our recent observation that a SNP in the KANSL1 gene promoter accounts for the AD association peak with MAPT (the gene encoding Tau) and co-regulates expression of alternatively spliced exon 3 in MAPT (Jun et al. 2016). This evidence concerns the gene MAPT and Alzheimer disease.